Phase II results of TaiwansCOVID-19 vaccine meet safety, efficacy thresholds Developer says no severe adverse reactions seen in trial so far Jun. 10, 2021 21:30# seroconversion rate# Phase II clinical trial# COVID-19 vaccine candidateDeveloper says no severe adverse reactions seen in trial so far # seroconversion rate# Phase II clinical trial# COVID-19 vaccine candidate
